Department of Health and Human Services, National Institutes of Health

Immune Tolerance Network (UM1 Clinical Trial Required)

Who can apply

  • Others (see eligibility details)
  • Independent school districts
  • Private colleges and universities
  • Special district governments
  • Public and state-controlled colleges
  • Federally recognized tribal governments
  • For-profit organizations (not small businesses)
  • Tribal organizations
  • County governments
  • State governments
  • Small businesses
  • City or township governments
  • Nonprofits with 501(c)(3) status
  • Public and tribal housing authorities
  • Nonprofits without 501(c)(3) status

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

About this grant

The purpose of this notice of funding opportunity (NOFO) is to support applications to continue the Immune Tolerance Network (ITN). The primary objective of the Network is to develop tolerogenic therapies for immune-mediated disorders. The three main clinical areas of work are: 1) Allergic diseases and asthma; 2) Autoimmune diseases; and 3) Immune-mediated consequences of transplantation. The core functions of the ITN include designing, conducting, and sharing the results of clinical trials and performing integrated mechanistic studies.

Program history

Topics

GrantCalendar is not affiliated with Department of Health and Human Services. Details can change, so confirm everything on the official listing before you apply. Spotted a mistake? Tell us.

Similar open grants

Get new grants every Monday

One short email with new grants and deadlines coming up in the next two weeks. Unsubscribe in one click.